Francis Sullivan, PhD
VP, Enzymology and Structural Biology
Francis joined Cogent in March 2021 and is responsible for enzymology, screening, and structural biology as part of Cogent’s drug discovery program. Francis comes most recently from Array BioPharma/Pfizer Boulder where he was senior director of enzymology/HTS and structural biology. In his 19+ years there, he was involved in all the programs that advanced compounds into the clinic. Prior to that, Francis was assistant director of enzymology for 12 years at Genetics Institute/Wyeth. Francis received his Ph.D. from the University of Colorado with Tom Cech and was a postdoctoral fellow at Harvard Medical School with Chris Walsh. In his spare time Francis meditates, teaches Buddhism, and rides his bike in Boulder, Colorado.